24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Cancer genetics<br />

P04.012<br />

A novel PtEN mutation in an italian family with hyperplastic<br />

polyposis <strong>of</strong> the colon in the context <strong>of</strong> cowden syndrome<br />

D. Turchetti 1,2 , L. M. Pradella 1 , C. Rossi 1 , A. Alberani 3 , F. Ferrara 3 , P. A. Fanti 4 ,<br />

G. Romeo 1 ;<br />

1 UO e Cattedra di Genetica Medica - Azienda Ospedaliero-Universitaria Policlinico<br />

S.Orsola-Malpighi, Bologna, Italy, 2 Dipartimento di Oncologia - Presidio<br />

Ospedaliero Bellaria-Maggiore, Bologna, Italy, 3 UO Gastroenterologia ed Endoscopia<br />

Digestiva - Presidio Ospedaliero Bellaria-Maggiore, Bologna, Italy, 4 UO<br />

Dermatologia - Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.<br />

Clinical manifestations <strong>of</strong> Cowden Syndrome, which is caused by mutations<br />

in the PTEN gene, are extremely variable . Among gastrointestinal<br />

manifestations, hamartomatous polyps are the typical lesions, but<br />

other polyp types, including hyperplastic, have been reported .<br />

We describe a family in which hyperplastic polyposis was the reason<br />

for referral to the genetic clinic and that was found to carry a novel<br />

PTEN mutation .<br />

The proband, a 46 year-old man, was referred to the cancer genetic<br />

clinic because <strong>of</strong> the endoscopic finding <strong>of</strong> colonic polyposis. Histology<br />

showed the polyps to be hyperplastic . Moreover, upper gastrointestinal<br />

endoscopy detected esophageal acanthosis and papillomatosis and<br />

HP-related gastritis . Physical examination revealed the presence <strong>of</strong><br />

macrocephaly (65cm), obesity and cutaneous papillomas . The mother,<br />

62 year-old, had also been diagnosed with hyperplastic polyposis and<br />

with carcinoma ex-adenoma <strong>of</strong> the left colon, for which had undergone<br />

hemicolectomy at age 61 . Previously, she had had hysterectomy for<br />

uterine fibroids at age 47 and mastectomy for invasive ductal carcinoma<br />

<strong>of</strong> the breast at age 51 . Physical examination showed macrocephaly<br />

(59cm), obesity, cutaneous papillomas and subcutaneous<br />

lipomas .<br />

PTEN mutational analysis in the proband revealed the germline heterozygous<br />

mutation 303delA in the exon 5, which was confirmed in the<br />

mother . This mutation, which to our knowledge has never been described<br />

before, generates a stop at codon 111, producing a truncated<br />

protein which looses three functionally relevant domains .<br />

To help clarify the pathogenic mechanism <strong>of</strong> the mutation, we are now<br />

performing molecular studies on pathologic tissues removed from the<br />

patients .<br />

P04.013<br />

Dysregulation <strong>of</strong> RAs signaling in colorectal carcinomas<br />

I. Bottillo 1 , I. Torrente 1 , T. Ahlquist 2 , S. A. Danielsen 2 , G. I. Meling 3 , R. A.<br />

Lothe 2 , B. Dallapiccola 1,4 ;<br />

1 CSS-Mendel Institute, Rome, Italy, 2 Department <strong>of</strong> Cancer Prevention, Institute<br />

for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Centre, Oslo,<br />

Norway, 3 Surgical Department, Faculty Division Akershus University Hospital,<br />

University <strong>of</strong> Oslo, Oslo, Norway, 4 Department <strong>of</strong> Experimental Medicine, Sapienza<br />

University, Rome, Italy.<br />

Half <strong>of</strong> all colorectal carcinomas (CRC) have dysregulation <strong>of</strong> the RAS<br />

signaling, increasing the cellular proliferative potential and resistance<br />

to apoptosis . KRAS is known to be commonly mutated in CRC, while<br />

mutational status <strong>of</strong> the NF1 gene, acting as a negative regulator <strong>of</strong><br />

RAS signaling, is not known . We analyzed a series <strong>of</strong> CRC for mutations<br />

in KRAS, BRAF, and NF1 . NF1 coding region screening was<br />

performed by dHPLC (denaturing high performance liquid chromatography),<br />

sequencing and MLPA (multiple ligation-dependent probe<br />

amplification). KRAS and BRAF were analyzed by sequencing . 40%<br />

(26/65) <strong>of</strong> the samples carried a mutation in KRAS, 22% (14/64) in<br />

BRAF, and 13% (3/24) in NF1 . We found that 62% (40/65) <strong>of</strong> the samples<br />

had alterations in one or more <strong>of</strong> the components, meaning they<br />

have a dysregulation <strong>of</strong> the RAS pathway . BRAF and KRAS mutations<br />

were mutually exclusive . BRAF mutation was strongly associated with<br />

microsatellite instability (MSI), female gender, and proximal location .<br />

Among the 24 samples analyzed for mutations in NF1, we found 2<br />

missense and 2 splicing mutations . All NF1 mutations occurred in MSI,<br />

proximal, and female-derived tumors with BRAF mutation . In addition,<br />

we found that 3 <strong>of</strong> the samples had duplication <strong>of</strong> parts or the whole<br />

NF1 gene . In conclusion RAS pathway is dysregulated by mutually<br />

exclusive mutations <strong>of</strong> KRAS and BRAF in the majority <strong>of</strong> CRC . We<br />

show that the activity <strong>of</strong> RAS signaling is likely to be enhanced in more<br />

than 10% <strong>of</strong> the tumors since they harbor mutations in both BRAF and<br />

NF1 .<br />

P04.014<br />

Age related differences in molecular pr<strong>of</strong>iles <strong>of</strong> colorectal<br />

cancers in patients from the Republic <strong>of</strong> macedonia<br />

M. Hiljadnikova - Bajro 1 , T. Josifovski 2 , A. Kapedanovska 1 , Z. Serafimoska 1 ,<br />

Z. Sterjev 1 , N. Matevska 1 , M. Panovski 2 , N. Petrusevska 2 , L. Suturkova 1 , A. J.<br />

Dimovski 1 ;<br />

1 Faculty <strong>of</strong> Pharmacy, Skopje, The former Yugoslav Republic <strong>of</strong> Macedonia,<br />

2 Faculty <strong>of</strong> Medicine, Skopje, The former Yugoslav Republic <strong>of</strong> Macedonia.<br />

Colorectal cancer (CRC) is considered a disease <strong>of</strong> elderly, though<br />

2-3% occurs in patients G (p .H1047R) in 3 cases . We also found c .3073 A>G<br />

(p .T1025A) and c .3145 G>C (p .G1049R) . In one case we found a mutation<br />

which, to our knowledge, has not been reported previously: c .<br />

3074 C>T (p .T1025I) .<br />

Two <strong>of</strong> the patients with exon 20 PIK3CA mutations had metastatic disease<br />

(33%), while 3 <strong>of</strong> 54 (5 .5%) patients with no mutations had metastasis<br />

(p=0 .07) . The mean age at diagnosis for patients with PIK3CA<br />

mutation was 62 .8, and for patients without a mutation - 63 .3 .<br />

Somatic mutations in exon 20 <strong>of</strong> PIK3CA have been shown to be oncogenic<br />

as they lead to an increased PI3K activity . The PI3K regulate<br />

signaling pathways such as cell proliferation, survival and adhesion .<br />

Our results confirm that PIK3CA alterations may play an important role

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!